Bridgette Kelleher

Dr. Bridgette Kelleher


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
APAnita Panjwani
Anita Panjwani
RBRegan Bailey
Regan Bailey
BKBridgette Kelleher
Bridgette Kelleher

1 October 2017 in Sleep Medicine
Verified
Journal Article
Closed access
EAEmily A. Abel
Emily A. Abel
BKBridgette Kelleher
Bridgette Kelleher

28 July 2020 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
BKBridgette Kelleher
Bridgette Kelleher
THTaylor Halligan
Taylor Halligan
NWNicole Witthuhn
Nicole Witthuhn
WNWei Siong Neo
Wei Siong Neo
LHLisa Hamrick
Lisa Hamrick
LALeonard Abbeduto
Leonard Abbeduto
Background: Advances in clinical trials have revealed a pressing need for outcome measures appropriate for children with neurogenetic syndromes (NGS). However, the field lacks a standardized, flexible protocol for collecting laboratory-grade experimental data remotely. To address this challenge, we developed PANDABox (Parent-Administered Neurodevelopmental Assessment), a caregiver-facilitated, remotely administered assessment protocol for collecting integrated and high quality clinical, behavioral, and spectral data relevant to a wide array of research questions. Here, we describe PANDABox development and report preliminary data regarding: (1) logistics and cost, (2) caregiver fidelity and satisfaction, and (3) data quality. Methods: We administered PANDABox to a cohort of 16 geographically diverse caregivers and their infants with Down syndrome. Tasks assessed attention, language, motor, and atypical behaviors. Behavioral and physiological data were synchronized and coded offline by trained research assistants. Results: PANDABox required low resources to administer and was well received by families, with high caregiver fidelity (94%) and infant engagement (91%), as well as high caregiver-reported satisfaction (97% positive). Missing data rates were low for video frames (3%) and vocalization recordings (6%) but were higher for heart rate (25% fully missing and 13% partially missing) and discrete behavioral presses (8% technical issues and 19% not enough codable behavior), reflecting the increased technical demands for these activities. Conclusion: With further development, low-cost laboratory-grade research protocols may be remotely administered by caregivers in the family home, opening a new frontier for cost-efficient, scalable assessment studies for children with NGS other neurodevelopmental disorders.

14 October 2014 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
BKBridgette Kelleher
Bridgette Kelleher
MGMarjorie L. Grefer
Marjorie L. Grefer
DHDeborah D. Hatton
Deborah D. Hatton
JRJane Roberts
Jane Roberts

13 February 2018 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
BKBridgette Kelleher
Bridgette Kelleher
JRJohn E. Richards
John E. Richards
JRJane E. Roberts
Jane E. Roberts
Although aberrant visual attention has been identified in infants at high familial risk for autism, the developmental emergence of atypical attention remains unclear. Integrating biological measures of attention into prospective high-risk infant studies may inform more nuanced developmental trajectories, clarifying the onset and course of atypical attention and potentially advancing early screening or treatment protocols. Heart rate-defined sustained attention (HRDSA) is a well-validated biological measure of attentional engagement that, in non-clinical infant populations, provides incremental information about attentional engagement beyond looking behaviors alone. The present study aimed to examine the characteristics and clinical correlates of HRDSA in high-risk infants, informing whether HRDSA may operate as a promising biological measure of attention and clinical symptoms in this population. We examined age-related patterns of HRDSA during a passive looking task in 5- to 14-month-old high-risk infant siblings of children with autism (n = 21) compared to low-risk controls (n = 21), with most participants contributing multiple assessments. Emergent autism features were measured using the Autism Diagnostic Observation Schedule at 24 months. Primary dependent variables included the proportion of time in behavioral attention, proportion of time in HRDSA, and average heart rate deceleration during HRDSA. For each variable, we used nested multilevel models to examine whether attention differed by group, as well as whether attention predicted emergent autism features among high-risk infant siblings. As expected, HRDSA served as a global biological measure of attention in high-risk infants, predicting greater variability in group risk status than behavioral looking alone. Among high-risk infants, more severe ASD features were also associated with increasingly shallow heart rate deceleration during HRDSA across development, suggesting abnormal qualities of HRDSA may inform individual differences within this population. These preliminary findings provide initial evidence that HRDSA may offer a sensitive, affordable, and portable biological measure of attention that may enhance understanding of atypical attention in high-risk infants. Using this method, we also provide initial evidence that atypical patterns of heart activity previously reported in children and adults with autism may emerge in the first year of life, warranting further study of how HRDSA may specifically inform attention profiles in ASD.

1 February 2021 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
WNWei Siong Neo
Wei Siong Neo
TSTakakuni Suzuki
Takakuni Suzuki
BKBridgette Kelleher
Bridgette Kelleher